Cryptosporidium Parvum Biliary Tract Infection in Adult Immunocompetent and Immunosuppressed Mice

References

1. Current W. L., Garcia L. S. Cryptosporidiosis. Clin Microbiol Rev 1991; 4:325–358
   [Google Scholar]
2. Benhamou Y., Caumes E., Gerosa Y. AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients. Dig Dis Sci 1993; 38:1113–1118
   [Google Scholar]
3. Forbes A., Blanshard C., Gazzard B. Natural history of AIDS related sclerosing cholangitis: a study of 20 cases. Gut 1993; 34:116–121
   [Google Scholar]
4. Cello J. P. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989; 86:539–546
   [Google Scholar]
5. Vakil N. B., Schwartz S. M., Buggy B. P. Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996; 334:19–23
   [Google Scholar]
6. Ungar B. L. P., Burris J. A., Quinn C. A., Finkelman F. D. New mouse models for chronic Cryptosporidium infection in immunodefi-cient hosts. Infect Immun 1990; 58:961–969
   [Google Scholar]
7. Mead J. R., Arrowood M. J., Sidwell R. W., Healey M. C. Chronic Cryptosporidium parvum infections in congenitally immunode-ficient SCID and nude mice. J Infect Dis 1991; 163:1297–1304
   [Google Scholar]
8. Brasseur P., Lemeteil D., Ballet J. J. Curative and preventive anticryptosporidium activities of sinefungin in an immunosup-pressed adult rat model. Antimicrob Agents Chemother 1993; 37:889–892
   [Google Scholar]
9. Mead J. R., Ilksoy N., You X. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun 1994; 62:1691–1695
   [Google Scholar]
10. Regh J. E. A comparison of anticryptosporidial activity of halofuginone with that of other aminoglycosides and azithromycin in immunosuppressed rats. J Antimicrob Chemother 1994; 170:934–938
    [Google Scholar]
11. Tzipori S. T., Rand W., Theodos C. Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. J Infect Dis 1995; 172:1160–1164
    [Google Scholar]
12. Ungar B. L. P., Soave R., Fayer R., Nash T. E. Enzyme immunoassay of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis 1986; 153:570–578
    [Google Scholar]
13. Chrisp C. E., Reid W. C., Rush H. G., Suckow M. A., Bush A., Thomann M. J. Cryptosporidiosis in guinea pigs: an animal model. Infect Immun 1990; 58:674–679
    [Google Scholar]
14. Johansen G. A., Sterling C. R. Detection of a prolonged C. parvum infection in immunocompetent adult C57BL/6 mice. J Eukaryot Microbiol 1994; 41: 45S:
    [Google Scholar]
15. Campbell A. T., Robertson L. J., Smith H. V. Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion of fluorogenic vital dyes. Appl Environ Microbiol 1992; 58: Suppl 3488–3493
    [Google Scholar]
16. Gut J., Petersen C., Nelson R., Leech J. Cryptosporidium parvum: in vitro cultivation in Madin-Darby canine kidney cells. J Protozool 1991; 38:72S–73S
    [Google Scholar]
17. Rasmussen K. R., Healey M. C. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect Immun 1992; 60:1648–1652
    [Google Scholar]